X4 Pharmaceuticals Inc (NASDAQ:XFOR)
| 0.7726 Delayed Data As of Nov 28 |  +0.0026 / +0.34%Today’s Change | 0.65 Today|||52-Week Range 2.58 | -22.20% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 3.5M | |
| Depreciation And Amortization | 400.0K | 300.0K | 200.0K | 155.0K | ||
| Operating Expenses | Gross Income | -400.0K | -300.0K | -200.0K | -- | |
| General Expenses | 14.4M | 24.0M | 35.9M | 45.7M | ||
| Research And Development | 12.7M | 17.8M | 28.1M | 31.0M | ||
| Total Operating Expenses | 14.8M | 24.3M | 36.1M | 45.9M | ||
| Non-Operating Expenses | Operating Income | -14.8M | -24.3M | -36.1M | -42.4M | |
| Extraordinary Credit | 1.0K | 1.4M | 731.0K | 0.00 | ||
| Extraordinary Charge | 0.00 | -35.0K | -462.0K | -3.5M | ||
| Interest Expense On Debt | 472.0K | 2.5M | 2.1M | 1.0M | ||
| Other Expenses | -77.0K | 104.0K | -16.0K | -85.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -13.2M | -23.0M | -33.9M | -43.0M | |
| Preferred Dividend | -19.0K | -25.0K | -44.0K | 0.00 | ||
| Net Income | -13.2M | -23.0M | -33.9M | -43.0M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 313.6K | 397.1K | 57.3K | -- | |
| Shares To Calculate EPS Diluted | 313.6K | 397.1K | 57.3K | -- | ||
| Earnings Per Share | EPS | -$42.22 | -$57.92 | -$592.20 | -- | |
| EPS Diluted | -$42.22 | -$57.92 | -$592.26 | -- | ||
